COMMUNIQUÉS West-GlobeNewswire

-
Apnimed Announces Completion of Enrollment in Phase 3 LunAIRo Study of AD109, the Potential First Nighttime Oral Treatment for Obstructive Sleep Apnea
09/05/2024 -
PMV Pharmaceuticals Reports First Quarter 2024 Financial Results and Corporate Highlights
09/05/2024 -
Bionano Announces Series of Major Advancements to its Suite of Computational Tools for Comprehensive Cancer Analysis
09/05/2024 -
ACELYRIN, INC. Announces Leadership Transition
09/05/2024 -
RAPT Therapeutics Reports First Quarter 2024 Financial Results
09/05/2024 -
NewAmsterdam Pharma Provides Corporate Update and Reports First Quarter Financial Results
09/05/2024 -
Fulcrum Therapeutics to Participate in Upcoming May Conferences
09/05/2024 -
PDS Biotech to Participate in Upcoming May 2024 Investor Conferences
09/05/2024 -
Intercept Announces New PBC Data Analyses to be Presented at Digestive Disease Week® 2024 Conference
09/05/2024 -
AEON Biopharma Provides Update on Development Pipeline
09/05/2024 -
ProPhase Labs Announces Financial Results for the Three Months Ended March 31, 2024, and Highlights Significant Progress in its Strategic Initiatives.
09/05/2024 -
NEXGEL to Report First Quarter 2024 Financial Results on May 13th
09/05/2024 -
Mounting Evidence that use of the Mental Health Collaborative Care Model is Associated with Reductions in Total Healthcare Costs
09/05/2024 -
Virios Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update
09/05/2024 -
Black Diamond Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
09/05/2024 -
Cronos Group Reports 2024 First Quarter Results
09/05/2024 -
Sensei Biotherapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
09/05/2024 -
Annovis Announces Unblinding of the Buntanetap Phase III Data in Parkinson’s Disease
09/05/2024 -
Lexicon Pharmaceuticals to Participate in the Bank of America Securities Healthcare Conference 2024
09/05/2024
Pages